Skip to main content
Cyber Week Sale - Get 40% off Vantage
Published loading...Updated

FDA in Turmoil After Exit of Veteran Cancer Researcher

Pazdur’s retirement highlights tensions over political influence and drug review speed, raising concerns about FDA’s safety standards amid leadership turnover, sources say.

Summary by KIFI
By Sarah Owermohle, Adam Cancryn, CNN (CNN) — Food and Drug Administration Commissioner Marty Makary is under renewed scrutiny by Trump officials amid continued turmoil at the agency, including a series of high-profile departures that have raised questions in the administration about Makary’s ability to lead, according to two people familiar with conversations. The pending exit of Dr. Richard Pazdur, a veteran researcher who pioneered the FDA’s …

9 Articles

Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 72% of the sources are Center
72% Center

Factuality Info Icon

To view factuality data please Upgrade to Premium

Ownership

Info Icon

To view ownership data please Upgrade to Vantage

The Cancer Letter broke the news in on Friday, December 5, 2025.
Too Big Arrow Icon
Sources are mostly out of (0)

Similar News Topics

News
Feed Dots Icon
For You
Search Icon
Search
Blindspot LogoBlindspotLocal